Prelude Therapeutics
PRLD
PRLD
58 hedge funds and large institutions have $162M invested in Prelude Therapeutics in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Holders
58
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$154K | |
| 2 | +$135K | |
| 3 | +$119K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$95.1K |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$93.9K |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$1.2M | |
| 3 | -$561K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$478K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$311K |